PT3204038T - Composições que compreendem amilase para utilização no tratamento do prurido - Google Patents

Composições que compreendem amilase para utilização no tratamento do prurido

Info

Publication number
PT3204038T
PT3204038T PT158482505T PT15848250T PT3204038T PT 3204038 T PT3204038 T PT 3204038T PT 158482505 T PT158482505 T PT 158482505T PT 15848250 T PT15848250 T PT 15848250T PT 3204038 T PT3204038 T PT 3204038T
Authority
PT
Portugal
Prior art keywords
kits
compositions
methods
same
treating pruritus
Prior art date
Application number
PT158482505T
Other languages
English (en)
Original Assignee
Rochal Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rochal Tech Llc filed Critical Rochal Tech Llc
Publication of PT3204038T publication Critical patent/PT3204038T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003Triacylglycerol lipase (3.1.1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01001Alpha-amylase (3.2.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01002Beta-amylase (3.2.1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01003Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24003Microbial collagenase (3.4.24.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT158482505T 2014-10-10 2015-10-08 Composições que compreendem amilase para utilização no tratamento do prurido PT3204038T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/511,988 US20160101166A1 (en) 2014-10-10 2014-10-10 Compositions and kits for treating pruritus and methods of using the same

Publications (1)

Publication Number Publication Date
PT3204038T true PT3204038T (pt) 2022-06-06

Family

ID=55653769

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158482505T PT3204038T (pt) 2014-10-10 2015-10-08 Composições que compreendem amilase para utilização no tratamento do prurido

Country Status (12)

Country Link
US (2) US20160101166A1 (pt)
EP (1) EP3204038B1 (pt)
JP (1) JP6669334B2 (pt)
AU (1) AU2015330889B2 (pt)
BR (1) BR112017006925B1 (pt)
CA (1) CA2963812A1 (pt)
DK (1) DK3204038T3 (pt)
ES (1) ES2914615T3 (pt)
MX (1) MX2017004198A (pt)
NZ (1) NZ730769A (pt)
PT (1) PT3204038T (pt)
WO (1) WO2016057789A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9592280B2 (en) * 2014-10-10 2017-03-14 Rochal Industries Llc Compositions and kits for enzymatic debridement and methods of using the same
US10238719B2 (en) 2014-10-10 2019-03-26 Rochal Industries, Llc Compositions and kits for enzymatic debridement and methods of using the same
JP6808628B2 (ja) * 2015-08-07 2021-01-06 株式会社カネカ 貼付剤
RU2647372C1 (ru) * 2017-04-17 2018-03-15 Александр Ливиевич Ураков Крем от обморожений
WO2019152110A1 (en) * 2018-01-31 2019-08-08 Kci Usa, Inc. Antimicrobial composition, dressing, dressing components, and method
US11439659B2 (en) * 2018-12-03 2022-09-13 The Regents Of The University Of California Methods and compositions to prevent and treat inflammation and allergic reactions
US10961662B1 (en) 2019-12-23 2021-03-30 Polymer Ventures, Inc. Ash retention additive and methods of using the same
FR3108841B1 (fr) * 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
FR3127688A1 (fr) * 2021-10-01 2023-04-07 Algotherapeutix Composition pharmaceutique topique sous forme de gel comprenant au moins de l’amitriptyline pour son utilisation dans le traitement des douleurs neuropathiques induites par un coronavirus
FR3127689A1 (fr) * 2021-10-01 2023-04-07 Algotherapeutix Composition pharmaceutique topique sous forme de gel comprenant au moins de l’amitriptyline pour son utilisation dans le traitement des douleurs neuropathiques du membre fantôme

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2120667A (en) 1937-12-01 1938-06-14 Lakeland Foundation Therapeutic agent for use in the treatment of infection
US2917433A (en) 1956-04-02 1959-12-15 Rystan Company Stable aqueous papain topical compositions
US3003917A (en) * 1959-01-14 1961-10-10 Nat Drug Co Wound healing composition
US3409719A (en) 1967-05-23 1968-11-05 Baxter Laboratories Inc Debridement agent
WO1984002846A1 (en) 1983-01-21 1984-08-02 Advanced Drug Tech Enzyme ointment
US4719235A (en) 1984-10-16 1988-01-12 Gerald N. Kern Methods and compositions for treating viral infection
US4668228A (en) 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
US4885310A (en) 1985-05-09 1989-12-05 Gerald N. Kern Anti-fungal methods and agent
US4717737A (en) 1985-06-05 1988-01-05 Gerald N. Kern Anti-bacterial methods and agent
US4772465A (en) 1986-10-27 1988-09-20 Miles Laboratories, Inc. Method of treating polymicrobial burn wound sepsis with a combination therapy of ciprofloxacin and pseudomonas immune globulin
US5206026A (en) 1988-05-24 1993-04-27 Sharik Clyde L Instantaneous delivery film
US5120656A (en) 1989-08-18 1992-06-09 Osteotech, Inc. Process for debriding bone
CA2041871C (en) * 1990-05-09 2000-07-11 Ruth A. Rosenthal Contact lens cleaning and disinfecting with combinations of polymeric quaternary ammonium compounds and enzymes
US5543149A (en) 1995-03-01 1996-08-06 Rubin; Stan M. Treatment for insect bites
US5670142A (en) 1996-07-08 1997-09-23 Donald Neudecker Treatment for itch of chicken pox
AU3006899A (en) 1998-03-13 1999-09-27 Biomarin Pharmaceutical Inc. Carbohydrate-modifying enzymes for burn and wound debridement and methods for treatment
US6548556B2 (en) 2000-12-27 2003-04-15 Healthpoint, Ltd. Stable enzymatic wound debrider
US7223386B2 (en) * 2002-03-11 2007-05-29 Dow Corning Corporation Preparations for topical skin use and treatment
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US20070237812A1 (en) * 2006-04-11 2007-10-11 Tyco Healthcare Group Multi-layer wound dressings
US7241456B2 (en) * 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use
US7368128B2 (en) 2003-10-10 2008-05-06 Coloplast A/S Controlled release dressing for enzymatic debridement of necrotic and non-viable tissue in a wound
IL165334A0 (en) 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
US8754045B2 (en) 2006-05-12 2014-06-17 James A. Livingston Enzymatic debridement therapy for abnormal cell proliferation
US7629158B2 (en) 2006-06-16 2009-12-08 The Procter & Gamble Company Cleaning and/or treatment compositions
WO2008021987A2 (en) * 2006-08-10 2008-02-21 Jon Barron Proteolytic enzyme formulations
WO2010004367A1 (en) 2008-07-10 2010-01-14 Life Science Investments Ltd Use of a mixture of superoxide dismutase and catalase for treating pruritus and alleviating its symptoms
RU2407512C1 (ru) * 2009-06-24 2010-12-27 Сергей Борисович Улитовский Безабразивная зубная паста, содержащая ферменты папаин, декстраназу, альфа-амилазу, калия или аммония тиоцианат, инвертазу или глюкоамилазу, глюкозооксидазу, лактопероксидазу, лизоцим или лактоферрин и лактулозу
US8486664B2 (en) 2010-07-29 2013-07-16 Basf Se Enzymatic production of an ethylenically unsaturated glycoside using polysaccharides
PL2598645T3 (pl) 2010-07-29 2014-10-31 Basf Se Sposób wytwarzania glikozydowych pochodnych akrylanu wykorzystujący polisacharydy i glikozydazy lub glikozylotransferazy
US20120104047A1 (en) * 2010-11-01 2012-05-03 Lim Walter K Composition for Relief of Insect Bites and Stings and Apparatus and Method for Its Delivery
WO2012155027A1 (en) 2011-05-12 2012-11-15 Healthpoint, Ltd. Wound debridement compositions containing seaprose and methods of wound treatment using same
EP2736486B1 (en) * 2011-07-28 2019-03-06 3M Innovative Properties Company Wound-healing compositions and method of use
WO2013116732A1 (en) * 2012-02-02 2013-08-08 Curelon Llc Enzyme compositions and use thereof for wound healing
US20130273026A1 (en) * 2012-04-12 2013-10-17 Integrative Enzymatics, Inc. Composition and method for modulating inflammatory molecules with amylase
US20130287859A1 (en) 2012-04-26 2013-10-31 Lescarden Inc. Method for treating prupritus with cartilage extract
CN102973927A (zh) * 2012-11-29 2013-03-20 李安平 止痒卫生纸制造方法
US20150086529A1 (en) 2013-09-26 2015-03-26 Barbara Ann Hillenbrand Therapeutic Burn Gel

Also Published As

Publication number Publication date
AU2015330889B2 (en) 2021-01-07
DK3204038T3 (da) 2022-06-13
JP6669334B2 (ja) 2020-03-18
JP2017530164A (ja) 2017-10-12
US20160199459A1 (en) 2016-07-14
WO2016057789A1 (en) 2016-04-14
EP3204038A4 (en) 2018-06-13
EP3204038B1 (en) 2022-05-04
AU2015330889A1 (en) 2017-04-27
NZ730769A (en) 2024-02-23
US10688159B2 (en) 2020-06-23
EP3204038A1 (en) 2017-08-16
CA2963812A1 (en) 2016-04-14
BR112017006925B1 (pt) 2023-12-12
MX2017004198A (es) 2017-07-19
BR112017006925A2 (pt) 2017-12-12
US20160101166A1 (en) 2016-04-14
ES2914615T3 (es) 2022-06-14

Similar Documents

Publication Publication Date Title
HRP20192145T1 (hr) Pripravci nosača-antitijela i metode pripreme i uporabe istih
HK1245326A1 (zh) 用於生產scaav的組合物和方法
HK1243640A1 (zh) 用於治療潰瘍的方法和組合物
ZA201707303B (en) Compositions and methods for the treatment of immunodeficiency
IL251759A0 (en) Preparations and methods for treating insomnia
PT3204038T (pt) Composições que compreendem amilase para utilização no tratamento do prurido
HUE056172T2 (hu) Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra
IL246879B (en) Preparations of Epilimod and methods of using them
IL249475A0 (en) Methods for treating itching
IL251546A0 (en) Preparations and kits for enzymatic fertilization and methods of using them
EP4043567C0 (en) METHOD AND COMPOSITIONS FOR TREATMENT OF CANCER
HK1246206A1 (zh) 用於治療青光眼的組合物和方法
EP3220908A4 (en) Compositions and methods for treating endometriosis
ZA201703771B (en) Compositions and methods for treating hyperkalemia
PT3113774T (pt) Composições de grapiprant e métodos de utilização das mesmas
HK1243404A1 (zh) 色酰胺組合物和使用方法
GB201417372D0 (en) Methods and kits
IL248846A0 (en) Methods and preparations of dezotraline for the treatment of adhd
GB201418268D0 (en) Composition & methods of treatment
GB201418272D0 (en) Composition & methods of treatment
GB201421904D0 (en) Methods and kits